Nalaganje...
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Thirty-seven carbapenem-resistant Enterobacteriaceae (CRE)-infected patients were treated with ceftazidime-avibactam. Clinical success and survival rates at 30 days were 59% (22/37) and 76% (28/37), respectively. In 23% (5/22) of clinical successes, CRE infections recurred within 90 days. Microbiolo...
Shranjeno v:
| izdano v: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5146720/ https://ncbi.nlm.nih.gov/pubmed/27624958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw636 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|